Related Experiment Videos
[Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)]
Insights
Labetalol effectively treats hypertensive emergencies by significantly lowering blood pressure and heart rate in patients. This medication is recommended for its efficacy and minimal side effects in emergency hypertension management.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertensive emergencies represent a critical threat to cardiovascular health.
- Rapid and effective blood pressure reduction is essential in managing these acute conditions.
Purpose:
- To evaluate the efficacy and safety of intravenous labetalol in treating hypertensive emergencies.
Summary:
- Thirty-six patients with hypertensive emergencies received an initial 100 mg intravenous bolus of labetalol.
- Mean blood pressure decreased from 220/128 mm Hg to 167/107 mm Hg, with a heart rate reduction from 85 to 76 bpm.
- Seven patients did not respond initially; two of four who received a second dose showed further blood pressure decrease.
Impact:
- Intravenous labetalol demonstrates significant efficacy in managing hypertensive emergencies.
- The drug is noted for its ease of administration and favorable side effect profile.
- Labetalol is recommended for clinical use in emergency settings for acute hypertension control.
Abstract:
For treatment of hypertensive emergencies 36 patients received an intravenous bolus of 100 mg labetalol. The mean blood pressure of the whole group was decreased from 220/128 mm Hg to 167/107 mm Hg. Mean heart rate dropped from 85 to 76 per minute. 7 patients did not respond to treatment. Thereafter 4 patients received a second dose of 100 mg or 500 mg labetalol respectively, whereupon 2 showed a distinct drop in blood pressure. Simple handling and intensive efficacy and the lack of troublesome side effects recommend labetalol for the treatment of hypertensive emergencies.